- Home
- ORI vs HALO Comparison
ORI vs HALO Comparison
Compare ORI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORI | HALO |
|---|---|---|
| Founded | 1923 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 8.8B |
| IPO Year | 1994 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ORI | HALO |
|---|---|---|
| Price | $38.74 | $69.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $43.50 | ★ $78.64 |
| AVG Volume (30 Days) | 1.4M | ★ 1.4M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 9.47% | N/A |
| EPS Growth | ★ 14.81 | N/A |
| EPS | ★ 1.32 | 1.22 |
| Revenue | ★ $9,136,300,000.00 | $151,862,000.00 |
| Revenue This Year | $7.07 | $28.24 |
| Revenue Next Year | $6.86 | $12.56 |
| P/E Ratio | ★ $29.72 | $58.73 |
| Revenue Growth | ★ 10.99 | N/A |
| 52 Week Low | $35.60 | $47.74 |
| 52 Week High | $46.76 | $82.22 |
Technical Indicators
Market Signals| Indicator | ORI | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 38.33 | 60.37 |
| Support Level | $38.61 | $67.94 |
| Resistance Level | $43.46 | $70.93 |
| Average True Range (ATR) | 0.89 | 2.54 |
| MACD | -0.12 | 0.55 |
| Stochastic Oscillator | 17.27 | 63.73 |
Price Performance
Historical ComparisonAbout ORI Old Republic International Corporation
Old Republic International Corp is engaged in the business of insurance underwriting and related services. The company operates in two segments: Specialty Insurance and Title Insurance. The insurance provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others. The company generates the majority of its revenue from Specialty Insurance. The Specialty Insurance provides property and liability insurance principally to commercial clients.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.